APA (7th ed.) Citation

Guilhaumou, R., Benaboud, S., Bennis, Y., Dahyot-Fizelier, C., Dailly, E., Gandia, P., . . . Garnier, M. (2019). Optimization of the treatment with beta-lactam antibiotics in critically ill patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française de Pharmacologie et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française d’Anesthésie et Réanimation—SFAR). Critical care (London, England), 23(1), 104-20. https://doi.org/10.1186/s13054-019-2378-9

Chicago Style (17th ed.) Citation

Guilhaumou, Romain, et al. "Optimization of the Treatment with Beta-lactam Antibiotics in Critically Ill Patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française De Pharmacologie Et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française D’Anesthésie Et Réanimation—SFAR)." Critical Care (London, England) 23, no. 1 (2019): 104-20. https://doi.org/10.1186/s13054-019-2378-9.

MLA (9th ed.) Citation

Guilhaumou, Romain, et al. "Optimization of the Treatment with Beta-lactam Antibiotics in Critically Ill Patients—guidelines from the French Society of Pharmacology and Therapeutics (Société Française De Pharmacologie Et Thérapeutique—SFPT) and the French Society of Anaesthesia and Intensive Care Medicine (Société Française D’Anesthésie Et Réanimation—SFAR)." Critical Care (London, England), vol. 23, no. 1, 2019, pp. 104-20, https://doi.org/10.1186/s13054-019-2378-9.